Biomarkers in COVID-19: an up-to-date review
M Samprathi, M Jayashree - Frontiers in pediatrics, 2021 - frontiersin.org
The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses several challenges
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …
SARS-CoV-2 infections in children and young people
S Felsenstein, CM Hedrich - Clinical immunology, 2020 - Elsevier
Though recent reports link SARS-CoV-2 infections with hyper-inflammatory states in
children, most children experience no/mild symptoms, and hospitalization and mortality rates …
children, most children experience no/mild symptoms, and hospitalization and mortality rates …
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of …
KC Gedik, L Lamot, M Romano, E Demirkaya… - Annals of the …, 2022 - ard.bmj.com
Objective Autoinflammatory type I interferonopathies, chronic atypical neutrophilic
dermatosis with lipodystrophy and elevated temperature/proteasome-associated …
dermatosis with lipodystrophy and elevated temperature/proteasome-associated …
COVID-19 and dentistry in 72 questions: An overview of the literature
The outbreak of Coronavirus Disease 2019 (COVID-19), caused by Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has significantly affected the dental …
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has significantly affected the dental …
Recommendations on off-label drug use in pediatric guidelines
M Meng, Q Zhou, W Lei, M Tian, P Wang… - Frontiers in …, 2022 - frontiersin.org
Objective: To systematically analyze the supporting evidence, drug information, and the type
of off-label drug use in recommendations on off-label drug use in pediatric guidelines …
of off-label drug use in recommendations on off-label drug use in pediatric guidelines …
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases
U Kaya Akca, E Atalay, MK Cuceoglu, Z Balik… - Rheumatology …, 2022 - Springer
The impact of the COVID-19 pandemic, and implemented restrictions on the frequency of
pediatric rheumatic diseases remain unknown, while they have probably prevented common …
pediatric rheumatic diseases remain unknown, while they have probably prevented common …
Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names
E1094 CMAJ| SEPTEMBER 21, 2020| VOLUME 192| ISSUE 38 with positive results for
SARS-CoV-2 testing are asymptomatic or have mild disease during the acute infectious …
SARS-CoV-2 testing are asymptomatic or have mild disease during the acute infectious …
Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases
DS Villacis-Nunez, CA Rostad, K Rouster-Stevens… - Pediatric …, 2021 - Springer
Background There are few reports of COVID-19 in pediatric patients with rheumatic
diseases. This study describes the clinical presentation and outcomes of COVID-19 in this …
diseases. This study describes the clinical presentation and outcomes of COVID-19 in this …
COVID-19 in children with rheumatic diseases in the Spanish National Cohort EPICO-AEP
C Calvo, C Udaondo… - The Journal of …, 2021 - jrheum.org
SARS-CoV-2 infection in children is relatively mild. Approximately 10% of identified cases
are pediatric, 1 with a small proportion needing hospitalization. About 25–60% of children …
are pediatric, 1 with a small proportion needing hospitalization. About 25–60% of children …
COVID-19 in Pediatrics
In 2019, a novel coronavirus emerged called severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). Initially identified in …
2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). Initially identified in …